Neuberger Berman Group
CBST

Neuberger Berman Group’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Neuberger Berman Group’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-343,028
Closed -$22.8M – 1748
2014
Q3 		$22.8M Sell
343,028
-22
-0% -$1.45K 0.02% 643
2014
Q2 		$24M Buy
343,050
+119,550
+53% +$8.13M 0.02% 617
2014
Q1 		$16.3M Buy
223,500
+1,250
+0.6% +$93.2K 0.02% 700
2013
Q4 		$15.3M Buy
222,250
+56,500
+34% +$3.66M 0.02% 704
2013
Q3 		$10.5M Buy
+165,750
New +$10M 0.01% 772

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Neuberger Berman Group's CBST Position: Q4 2014 in Review

Neuberger Berman Group sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q4 2014, closing a stake of 343,028 shares — an estimated $22.8M sold.

Neuberger Berman Group first reported a position in CBST in Q3 2013 and held it in 5 quarters. The position peaked at $24M in Q2 2014. 307 funds tracked by Wall St. Rank hold CBST as of Q4 2014.

  • Neuberger Berman Group reported no remaining CUBIST PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • Neuberger Berman Group sold 343,028 CUBIST PHARMACEUTICALS INC shares in Q4 2014, an estimated $22.8M.
  • Neuberger Berman Group first reported a position in CUBIST PHARMACEUTICALS INC in Q3 2013 and held it in 5 quarters.
  • Neuberger Berman Group's CUBIST PHARMACEUTICALS INC position peaked at $24M in Q2 2014.
  • 307 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q4 2014.

Based on Neuberger Berman Group's 13F filing for Q4 2014, filed 5 Feb 2015.